Molekule for Allergic Rhinitis/Asthma

Stopped early · Not applicable · Has a placebo group

Conditions studied: Asthma, Allergic Rhinitis, Allergic Conjunctivitis

In brief

Exposure to airborne allergens and pollutants is linked to symptom severity of allergies, asthma and other respiratory problems. In this study an air purifier using photo-electrochemical oxidation technology (PECO) will be used in the home environment of study participants. The investigator will assess the reduction of symptoms from allergic rhinitis/conjunctivitis and asthma.

Key facts

Study ID

NCT03627689

Run by

Molekule

People needed

49

Starts

2018-07-13

Expected to finish

2019-01-31

Last updated by the study team

2019-02-05

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Chronic allergic rhinitis and/or conjunctivitis by history
• History of adult asthma requiring medications now or in the past
• Age ≥18
• CARAT score less than 24

You may not qualify if…

• Participant is <18 years-old
• Use of systemic corticosteroids within 14 days of study initiation
• Treatment with biologic agents or allergen immunotherapy
• Treatment with other immunomodulators (cyclosporine, azathioprine, hydroxychloroquine, etc)
• Sensitive to fan sound or blue/purple light at night time

Where it is running

• Molekule — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.